Updated: January 20, 2026
How to Help Your Patients Find Forteo in Stock: A Provider's Guide
Author
Peter Daggett

Summarize with AI
- Step 1: Verify Insurance Coverage and Formulary Status Before You Prescribe
- Step 2: Submit Prior Authorization the Same Day
- Step 3: Route to the Right Specialty Pharmacy
- Step 4: Address Cost Barriers at the Point of Prescribing
- Step 5: Use medfinder for Providers When Urgency Is High
- Step 6: Educate the Patient on Administration and Storage
- The Bottom Line
A practical provider's guide to navigating Forteo access barriers in 2026—from specialty pharmacy routing to PA workflows and patient savings programs.
Prescribing Forteo (teriparatide) is only the first step. For many patients, the bigger challenge is actually getting the medication. As a clinician, the steps you take at the point of prescribing—and in the weeks after—can dramatically affect whether your patient starts and stays on therapy.
This guide provides a practical, step-by-step approach to navigating Forteo access barriers in 2026.
Step 1: Verify Insurance Coverage and Formulary Status Before You Prescribe
Coverage for Forteo varies widely by plan. Before you write the prescription, have your staff or prior authorization team verify:
Is teriparatide (brand or generic) covered under this plan?
Is generic teriparatide preferred over brand Forteo?
Does the plan mandate use of a specific specialty pharmacy?
What are the step therapy or prior authorization requirements?
Prescribing generic teriparatide (rather than Dispense As Written Forteo) often improves formulary access and can reduce the PA burden on your team.
Step 2: Submit Prior Authorization the Same Day
Prior authorization is required by most plans, including Medicare Part D. Don't wait for the pharmacy to trigger a rejection—that adds 2–5 days of delay. Submit the PA the same day you write the prescription.
A strong PA submission for teriparatide should include:
DEXA scan results (T-scores at spine and hip)
Fracture history (date, location, mechanism)
Prior bisphosphonate trial duration and reason for failure or intolerance
Clinical rationale for anabolic (bone-building) therapy vs. antiresorptive
For glucocorticoid-induced osteoporosis: current steroid dose, duration, and documentation of high fracture risk
Step 3: Route to the Right Specialty Pharmacy
Forteo is almost never dispensed at a standard retail pharmacy—it requires cold chain infrastructure. Route your patient to the appropriate specialty pharmacy before they head to their local CVS. Common specialty pharmacies that carry Forteo:
CVS Specialty
Walgreens Specialty (AllianceRx Walgreens Prime)
Accredo (Express Scripts Specialty)
Optum Specialty Pharmacy
Always check the patient's insurance plan for a mandated specialty pharmacy. If there is no mandate, use a pharmacy your practice has an established relationship with for faster coordination.
Step 4: Address Cost Barriers at the Point of Prescribing
Cost-related non-adherence is a major risk with specialty medications. Don't let it be a surprise at the pharmacy. At the point of prescribing, discuss:
Commercial insurance patients: The Forteo copay card from Eli Lilly can reduce monthly cost to as low as $4/month. Help patients enroll at forteo.lilly.com or through your office. The card covers up to $10,600/year.
Medicare patients: Manufacturer copay cards cannot be used with Medicare. Refer to the Lilly Cares Foundation Patient Assistance Program (lillycares.com) or Medicare Extra Help for eligible low-income patients.
Uninsured patients: The Lilly Cares Foundation PAP may provide Forteo at no cost for qualifying patients. GoodRx coupons for generic teriparatide can reduce the cost to approximately $1,146/pen.
Step 5: Use medfinder for Providers When Urgency Is High
For patients who need to start teriparatide urgently—such as those with a recent fragility fracture where delay increases re-fracture risk—use medfinder for Providers to locate retail or specialty pharmacies near the patient that currently have Forteo or generic teriparatide in stock. Providing your patient with a specific pharmacy name and phone number is far more actionable than telling them to 'call around.'
Step 6: Educate the Patient on Administration and Storage
Patient education at the point of prescribing improves adherence and reduces first-fill abandonment:
Forteo is injected once daily into the thigh or abdomen—same time each day is ideal but not required
The pen must be refrigerated at all times; it should NOT be left out or frozen
Orthostatic hypotension can occur, especially with the first few doses—advise patients to sit or lie down for the first injection and get up slowly
Use is limited to 2 years over the patient's lifetime—plan the transition to antiresorptive therapy before the course ends
The Bottom Line
Getting patients on and keeping them on teriparatide requires proactive steps at the point of prescribing. Verifying coverage, submitting PA early, routing to specialty pharmacy, and addressing cost upfront are the highest-leverage actions your practice can take. For a broader overview of the current landscape, see our Forteo provider briefing for 2026.
Frequently Asked Questions
Most Forteo prescriptions are best filled through specialty pharmacies that have cold chain capabilities—such as CVS Specialty, Walgreens Specialty, Accredo, or Optum Specialty. Always check the patient's insurance plan first, as many plans mandate a specific specialty pharmacy. For urgent needs, use medfinder for Providers to locate pharmacies with current stock.
For commercially insured patients: enroll them in the Forteo copay card (as low as $4/month, up to $10,600/year). For Medicare patients: refer to the Lilly Cares Foundation PAP (lillycares.com) or Medicare Extra Help. For uninsured patients: Lilly Cares PAP may provide Forteo at no cost; GoodRx coupons for generic teriparatide can reduce cost to approximately $1,146/pen.
PA timelines vary by payer but typically range from 2–10 business days. Submitting the PA the same day as the prescription, with complete clinical documentation (DEXA, fracture history, bisphosphonate trial failure), minimizes delays. Urgent PA review can sometimes be requested if the clinical situation warrants it.
Teriparatide (Forteo) use is limited to no more than 2 years over the patient's lifetime due to osteosarcoma concerns observed in animal studies (not confirmed in humans). Plan the transition to antiresorptive therapy (bisphosphonate or denosumab) before the 2-year course ends to preserve the bone density gains made on teriparatide.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Forteo also looked for:
More about Forteo
31,141 have already found their meds with Medfinder.
Start your search today.





